How to buy Edwards Lifesciences Corporation (EW) shares in the UK

Learn how to easily invest in Edwards Lifesciences Corporation shares.

Edwards Lifesciences Corporation (EW) is a leading medical devices business based in the US. It opened the day at $130.31 after a previous close of $130.68. During the day the price has varied from a low of $129.27 to a high of $130.94. The latest price was $129.55 (25 minute delay). Edwards Lifesciences Corporation is listed on the NYSE and employs 14,900 staff. All prices are listed in US Dollars.

How to buy shares in Edwards Lifesciences Corporation

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: EW in this case.
  5. Research Edwards Lifesciences Corporation shares. The platform should provide the latest information available.
  6. Buy your Edwards Lifesciences Corporation shares. It's that simple.
The whole process can take as little as 15 minutes.

How has coronavirus impacted Edwards Lifesciences Corporation's share price?

Since the stock market crash that started in February 2020, Edwards Lifesciences Corporation's share price has had significant positive movement.

Its last market close was $112.65, which is 31.58% up on its pre-crash value of $77.08 (accounting for the 31 May 2020 split) and 118.70% up on the lowest point reached during the March 2020 crash when the shares fell as low as $51.51 (accounting for the 31 May 2020 split).

If you had bought $1,000 worth of Edwards Lifesciences Corporation shares at the start of February 2020, those shares would have been worth $714.87 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,536.55.

Edwards Lifesciences Corporation share price (NYSE:EW)

Use our graph to track the performance of EW stocks over time.

Edwards Lifesciences Corporation shares at a glance

Information last updated 2021-12-31.
Previous close$130.68
Change %-0.8647%
Information last updated 2022-01-17.
52-week range$78.44 - $131.73
50-day moving average$119.5352
200-day moving average$109.2678
Wall St. target price$129.52
PE ratio50.8645
Dividend yieldN/A (0%)
Earnings per share (TTM)$2.325
eToro Free Stocks

Invest in Edwards Lifesciences Corporation shares with 0% commission

Other fees apply. Your capital is at risk.

  • Unlimited trades, with no dealing charges or management fees
  • Pay no stamp duty on UK shares (saving 0.5%)
  • Create an account today in a few minutes
Capital at risk

Fees for buying 5x Edwards Lifesciences Corporation shares with popular platforms

Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.

Platform Platform fee Min. initial deposit Trading fee estimate
eToro Free Stocks logo £0 $10 £2.41
£484.21 total
Capital at risk
Degiro Share Dealing logo £0 £0.01 £1.20
£483.00 total
Capital at risk
Stake logo £0 £50 £2.41
£484.21 total
Capital at risk
IG Share Dealing logo £0 £250 £9.88
£491.68 total
Capital at risk
Hargreaves Lansdown Fund and Share Account logo £0 £1 £16.77
£498.56 total
Capital at risk
interactive investor Trading Account logo £9.99 per month No minimum £15.22
£497.01 total
Capital at risk
Fineco logo £0 No minimum £4.82
£486.61 total
Capital at risk
Halifax Share Dealing Account logo £36 per year £20 £15.52
£497.32 total
Capital at risk

Full comparison of share dealing platforms

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is it a good time to buy Edwards Lifesciences Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Is Edwards Lifesciences Corporation under- or over-valued?

Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value.

P/E ratio

Edwards Lifesciences Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 51x. In other words, Edwards Lifesciences Corporation shares trade at around 51x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

PEG ratio

Edwards Lifesciences Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.5631. Higher PEG ratios such as this can be interpreted as meaning the shares offer worse value given the current rate of growth.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Edwards Lifesciences Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.


Edwards Lifesciences Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is a whopping $1.7 billion (£1.3 billion).

The EBITDA is a measure of a Edwards Lifesciences Corporation's overall financial performance and is widely used to measure a its profitability.


Revenue TTM $5.1 billion
Operating margin TTM 31.1%
Gross profit TTM $3.3 billion
Return on assets TTM 13.24%
Return on equity TTM 30.3%
Profit margin 29%
Book value $8.877
Market capitalisation $73.8 billion

TTM: trailing 12 months

Environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Edwards Lifesciences Corporation.

Total ESG risk score

Edwards Lifesciences Corporation's total ESG risk: 21.68

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Edwards Lifesciences Corporation's overall score of 21.68 (as at 12/31/2018) is pretty good – landing it in it in the 24th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Edwards Lifesciences Corporation is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Environmental score

Edwards Lifesciences Corporation's environmental score: 4.78/100

Edwards Lifesciences Corporation's environmental score of 4.78 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Edwards Lifesciences Corporation is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Social score

Edwards Lifesciences Corporation's social score: 13.43/100

Edwards Lifesciences Corporation's social score of 13.43 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Edwards Lifesciences Corporation is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Governance score

Edwards Lifesciences Corporation's governance score: 10.96/100

Edwards Lifesciences Corporation's governance score puts it squarely in the 6th percentile of companies rated in the same sector. That could suggest that Edwards Lifesciences Corporation is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Controversy score

Edwards Lifesciences Corporation's controversy score: 2/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. A high-profile company, Edwards Lifesciences Corporation scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Edwards Lifesciences Corporation has, for the most part, managed to keep its nose clean.

Environmental, social, and governance (ESG) summary

Edwards Lifesciences Corporation was last rated for ESG on: 2019-01-01.

Total ESG score 21.68
Total ESG percentile 24.1
Environmental score 4.78
Environmental score percentile 6
Social score 13.43
Social score percentile 6
Governance score 10.96
Governance score percentile 6
Level of controversy 2

Edwards Lifesciences Corporation share dividends

We're not expecting Edwards Lifesciences Corporation to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.

Have Edwards Lifesciences Corporation's shares ever split?

Edwards Lifesciences Corporation's shares were split on a 3:1 basis on 31 May 2020. So if you had owned 1 share the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Edwards Lifesciences Corporation shares – just the quantity. However, indirectly, the new 66.7% lower share price could have impacted the market appetite for Edwards Lifesciences Corporation shares which in turn could have impacted Edwards Lifesciences Corporation's share price.

Share price volatility

Over the last 12 months, Edwards Lifesciences Corporation's shares have ranged in value from as little as $78.44 up to $131.73. A popular way to gauge a stock's volatility is its "beta".

EW.US volatility(beta: 1.09)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Edwards Lifesciences Corporation's is 1.0933. This would suggest that Edwards Lifesciences Corporation's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Win £500 to get your trading started

Subscribe to trending stock alerts for a chance to win

By submitting, you agree to the Finder Privacy and Cookies Policy and Terms of Use

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site